The focus of the Medical Technology Conference, which will take place virtually at the end of September due to the Corona pandemic, will be on the opportunities offered by digitalization for medical technology companies and the future viability of medical technology.

Presentations on networked operating rooms and e-health (by Dr. Thomas Ramolla, Klinikum Stuttgart) and on strengthening companies in crisis (by Albrecht Broemme, reconcilia GmbH), supplemented by field reports from GHA members, will provide GHA members with a variety of insights.

Dirk Freiland, Managing Partner Clairfield International and Dr. Ulrich Philippi, Partner Luther Rechtsanwaltsgesellschaft will present the main findings of the medical technology market study to GHA members at the conference.

German medium-sized companies have so far been able to secure competitive advantages due to their strong innovative power. As a result of increased competitive and cost pressure, more stringent regulatory requirements and the new challenges posed by digitization, the medical technology industry is currently undergoing a process of far-reaching change, particularly in Germany and Europe. The corona pandemic has made this situation even worse for some companies. Previously successful business models and also the trade with medical products are coming under greater pressure than before, and companies are forced to critically question their current strategy, the resilience of their business model and the future viability of their product portfolio, so a recommendation of the study.